Cargando…

Silver and Copper Nanoparticles—An Alternative in Future Mastitis Treatment and Prevention?

Nowadays, mastitis is one of the biggest problems in breeding dairy cattle. Treatment of this disease with conventional antibiotics is ineffective because many pathogens are resistant. Researchers have therefore been forced to look for new solutions, and metal nanoparticles (NPs) have been found to...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalińska, Aleksandra, Jaworski, Sławomir, Wierzbicki, Mateusz, Gołębiewski, Marcin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6480535/
https://www.ncbi.nlm.nih.gov/pubmed/30987188
http://dx.doi.org/10.3390/ijms20071672
_version_ 1783413588458733568
author Kalińska, Aleksandra
Jaworski, Sławomir
Wierzbicki, Mateusz
Gołębiewski, Marcin
author_facet Kalińska, Aleksandra
Jaworski, Sławomir
Wierzbicki, Mateusz
Gołębiewski, Marcin
author_sort Kalińska, Aleksandra
collection PubMed
description Nowadays, mastitis is one of the biggest problems in breeding dairy cattle. Treatment of this disease with conventional antibiotics is ineffective because many pathogens are resistant. Researchers have therefore been forced to look for new solutions, and metal nanoparticles (NPs) have been found to be the most appropriate agents. This study uses commercially available silver (AgNPs) and copper (CuNPs) nanoparticles and synthetized silver–copper nanoparticles (AgCuNPs) to evaluate the effect of these NPs on human and bovine mammary cells. The effect of AgNPs, CuNPs, and AgCuNPs on pathogen species commonly involved in udder inflammation (e.g., Staphylococcus aureus and Escherichia coli) was also established. The results show that commercially available NPs were of good quality and did not have a toxic effect on mammary gland tissue. AgNPs, CuNPs, and AgCuNPs also influenced or decreased the viability of pathogens. Therefore, the presented data suggest that metal NPs could be used in mastitis prevention and treatment in the future. However, the presented preliminary results require further in vivo analysis.
format Online
Article
Text
id pubmed-6480535
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-64805352019-04-29 Silver and Copper Nanoparticles—An Alternative in Future Mastitis Treatment and Prevention? Kalińska, Aleksandra Jaworski, Sławomir Wierzbicki, Mateusz Gołębiewski, Marcin Int J Mol Sci Article Nowadays, mastitis is one of the biggest problems in breeding dairy cattle. Treatment of this disease with conventional antibiotics is ineffective because many pathogens are resistant. Researchers have therefore been forced to look for new solutions, and metal nanoparticles (NPs) have been found to be the most appropriate agents. This study uses commercially available silver (AgNPs) and copper (CuNPs) nanoparticles and synthetized silver–copper nanoparticles (AgCuNPs) to evaluate the effect of these NPs on human and bovine mammary cells. The effect of AgNPs, CuNPs, and AgCuNPs on pathogen species commonly involved in udder inflammation (e.g., Staphylococcus aureus and Escherichia coli) was also established. The results show that commercially available NPs were of good quality and did not have a toxic effect on mammary gland tissue. AgNPs, CuNPs, and AgCuNPs also influenced or decreased the viability of pathogens. Therefore, the presented data suggest that metal NPs could be used in mastitis prevention and treatment in the future. However, the presented preliminary results require further in vivo analysis. MDPI 2019-04-03 /pmc/articles/PMC6480535/ /pubmed/30987188 http://dx.doi.org/10.3390/ijms20071672 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kalińska, Aleksandra
Jaworski, Sławomir
Wierzbicki, Mateusz
Gołębiewski, Marcin
Silver and Copper Nanoparticles—An Alternative in Future Mastitis Treatment and Prevention?
title Silver and Copper Nanoparticles—An Alternative in Future Mastitis Treatment and Prevention?
title_full Silver and Copper Nanoparticles—An Alternative in Future Mastitis Treatment and Prevention?
title_fullStr Silver and Copper Nanoparticles—An Alternative in Future Mastitis Treatment and Prevention?
title_full_unstemmed Silver and Copper Nanoparticles—An Alternative in Future Mastitis Treatment and Prevention?
title_short Silver and Copper Nanoparticles—An Alternative in Future Mastitis Treatment and Prevention?
title_sort silver and copper nanoparticles—an alternative in future mastitis treatment and prevention?
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6480535/
https://www.ncbi.nlm.nih.gov/pubmed/30987188
http://dx.doi.org/10.3390/ijms20071672
work_keys_str_mv AT kalinskaaleksandra silverandcoppernanoparticlesanalternativeinfuturemastitistreatmentandprevention
AT jaworskisławomir silverandcoppernanoparticlesanalternativeinfuturemastitistreatmentandprevention
AT wierzbickimateusz silverandcoppernanoparticlesanalternativeinfuturemastitistreatmentandprevention
AT gołebiewskimarcin silverandcoppernanoparticlesanalternativeinfuturemastitistreatmentandprevention